시장보고서
상품코드
2038213

전용 주입 펌프용 일회용품 시장 규모 : 유형별, 용도별, 지역별 및 예측

Dedicated Infusion Pump Disposables Market Size By Type (Administration Sets, Syringes, Cartridges, Tubing & Connectors), By Application (Hospitals, Ambulatory Surgical Centers, Home Healthcare, Specialty Clinics), By Geographic Scope And Forecast

발행일: | 리서치사: 구분자 Verified Market Research | 페이지 정보: 영문 150 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    



가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.
US $ 3,950 금액 안내 화살표 ₩ 6,058,000
PDF & Excel (5 User License) help
PDF 및 Excel 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.
US $ 4,850 금액 안내 화살표 ₩ 7,438,000
PDF & Excel (Enterprise User License) help
PDF 및 Excel 보고서를 동일기업내 모든 분들이 이용할 수 있는 라이선스입니다. 보고서의 다운로드와 인쇄가 가능합니다.
US $ 7,550 금액 안내 화살표 ₩ 11,579,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 전용 주입 펌프용 일회용품 시장 규모와 예측

전용 주입 펌프용 일회용품 시장 규모는 2025년에 37억 2,000만 달러에 이르고, 2027년부터 2033년까지 예측 기간 중 CAGR 6.2%로 견고한 성장을 유지한다고 전망되고 있습니다. 디지털 수액 관리 시스템이나 약제 안전 모니터링 솔루션을 도입하는 기업 전체 대처가, 이 강력한 성장 주요 요인이 되고 있습니다. 이 시장은 2033년까지 60억 4,000만 달러에 이를 것으로 예측되며, 이것은 경제 정세 전체 큰 재평가를 시사하고 있습니다.

전 세계 전용 주입 펌프용 일회용품 시장 개요

전용 수액펌프용 일회용은 의료현장에서 수액펌프 시스템에 사용하기 위해 특별히 설계된 소모성 부품을 말합니다. 여기에는 정확한 약물 투여, 환자 안전 및 특정 펌프 모델과의 호환성을 보장하기 위해 설계된 튜브 세트, 카트리지, 커넥터와 같은 품목이 포함됩니다. 조달 주체는 일반적으로 병원, 클리닉, 재택치료 서비스 제공업체이며, 신뢰성, 규정 준수 및 일관된 성능을 중요시합니다. 수액 요법 및 환자별 투약 프로토콜의 확산으로 이러한 특수 소모품에 대한 안정적인 수요를 뒷받침하고 있습니다.

시장 조사에서 전용 주입 펌프 소모품은 데이터 수집, 비교 및 보고의 모든 과정에서 범위를 표준화하는 명명 체계로 취급되어 이해관계자나 시기에 관계없이 이러한 소모품에 대한 언급이 항상 동일한 기본 범주를 가리키도록 합니다.

수요는 병원, 외래, 재택의료 현장에서의 일관된 사용으로 형성되고 있으며, 이러한 현장에서는 수요량 확대보다는 환자 안전, 투약 정확성, 규제 준수에 우선순위를 두고 있습니다. 구매자는 일반적으로 의료 제공업체 및 조달 그룹에 집중되어 있으며, 급속한 확장보다는 공급의 신뢰성, 가격 안정성 및 의료 표준 준수 여부가 구매 결정에 영향을 미칩니다.

가격은 현물시장의 변동이 아닌 병원의 예산 및 임상 조달 주기에 따라 주기적으로 조정되기 때문에 원자재 비용 및 규제 요건에 따라 조정되는 형태입니다. 가까운 미래에는 의료 정책의 발전, 수액 요법의 보급률, 그리고 의료기기 및 일회용 제품 사용에 영향을 미치는 임상 가이드라인에 따라 달라질 것으로 예측됩니다.

전 세계 전용 주입 펌프용 일회용품 시장 활성화 요인

만성질환 치료에서 수액요법 수요 증가: 암, 당뇨, 심혈관질환 등 만성질환 유병률 증가로 인해 의료 시스템 전반에서 수액요법 시행 건수가 증가하고 있습니다. 각 주입 사이클에는 신뢰할 수 있는 일회용 부품이 필요하며, 지속적인 조달을 지원하고 있습니다. 화학요법, 면역요법, 항생제 투약 등 장기적인 치료는 전용 수액펌프용 액세서리의 지속적인 사용을 낳고 있습니다. 종양학과와 중환자실의 치료 프로그램 확대는 안정적인 수요 패턴을 촉진하고 있습니다. 최근 보고서에 따르면 2023년 전 세계 수액 요법 시행 횟수가 2억 5,000만 회를 넘어 일회용 제품의 지속적인 소비를 뒷받침하는 것으로 나타났습니다.

재택치료 및 외래 치료 모델 확대: 재택 및 외래 치료 서비스로 인해 휴대용 주입 펌프의 보급이 확대되고 있습니다. 병원 외의 환경에서 안전하게 사용하기 위해서는 호환 가능한 일회용 세트가 필요합니다. 항생제 치료, 통증 관리 약물, 영양 수액을 받는 환자들은 재택 수액 시스템에 의존하고 있습니다. 원격 치료 프로그램의 확대는 일회용 수액 액세서리의 소비 증가를 촉진하고 있습니다. 시장 분석에 따르면, 2023년 북미의 재택 수액 장치 도입 수는 전년 대비 약 12% 증가하여 일회용 제품에 대한 수요 증가가 두드러졌습니다.

감염 관리 및 환자 안전에 대한 중요성 증가: 엄격한 감염 예방 정책으로 인해 오염 위험을 최소화하기 위해 일회용 주입 펌프용 일회용 제품을 사용하는 것이 우선시되고 있습니다. 임상 안전 프로토콜에 따라 각 수액 주입 절차에서 멸균된 튜브, 커넥터 및 주사기 사용이 의무화되어 있습니다. 규제 당국은 안전한 약물 투여 환경을 유지하기 위해 일회용 부품의 사용을 강화하고 있습니다. 병원 내 감염률에 대한 지속적인 모니터링이 일회용 기준 준수를 촉진하고 있습니다. CDC의 보고에 따르면, 2023년 일회용 수액 프로토콜을 철저히 시행한 병원에서는 의료기기 관련 감염이 7% 감소하여 도입에 대한 효과를 보여주었습니다.

스마트 주입 펌프 시스템 통합: 최신 주입 펌프에 탑재된 소프트웨어 기반 투약 관리 시스템은 정확한 작동을 위해 전용 투약 세트와 호환 가능한 튜브를 필요로 합니다. 시스템 성능 및 규정 준수를 유지하기 위해 제조업체 인증 일회용 액세서리를 조달하고 있습니다. 첨단 주입 기술의 도입으로 특수 일회용 제품에 대한 수요가 증가하고 있습니다. 디지털 모니터링 기능은 일관된 일회용 부품의 성능에 의존하면서 투약 오류를 줄입니다. 2023년 조사에 따르면 유럽과 북미 병원의 약 68%가 스마트 주입 펌프를 사용하고 있으며, 이에 따라 호환 가능한 일회용 제품에 대한 수요도 비례적으로 증가하고 있습니다.

전 세계 전용 주입 펌프용 일회용품 시장 성장 억제요인

전체 의료 조달 예산의 비용 압박 증가: 병원 및 클리닉이 한정된 예산으로 늘어나는 치료 건수를 관리해야 하기 때문에 운영비 증가가 도입을 억제하고 있습니다. 적극적인 가격 협상이 조달 전략에 영향을 미치는 반면, 제조업체 간의 경쟁은 수익률에 압력을 가하고 있습니다. 비용 중심의 구매 결정으로 인해 일회용 제품의 활용 확대가 둔화되고 있습니다. 소규모 의료시설의 예산 제약으로 인해 전용 주입 펌프용 소모품의 대규모 조달이 제한되고 있습니다. 재정적 유연성의 부족은 의료 네트워크 전반에 걸쳐 새로운 일회용 기술의 도입을 더욱 지연시키고 있습니다.

의료 폐기물 발생에 대한 환경 문제: 병원에서는 관리된 폐기 처리가 필요한 플라스틱 수액 튜브, 주사기, 커넥터가 대량으로 발생하며, 일회용 소모품 증가로 인해 시장 확대가 제한되고 있습니다. 지속가능성에 대한 고려로 폐기물 감소에 대한 검토가 진행되고 있습니다. 의료폐기물 관리에 대한 규제 가이드라인이 운영상의 유연성을 제한하고 있습니다. 환경에 대한 관심이 높아지면서 대체품 및 재사용 가능한 솔루션의 도입이 서서히 진행되고 있습니다. 환경 친화적 의료행위에 대한 일반 시민과 기관의 관심이 높아지면서 일회용 제품 소비 패턴에 대한 압력이 증가하고 있습니다.

주입 펌프의 생태계와의 호환성에 대한 의존성: 특정 펌프 모델과의 독점적 호환성이 광범위한 채택을 방해하고 있습니다. 여러 브랜드를 운영하는 시설에서는 일회용 제품 재고를 개별적으로 관리해야 하기 때문입니다. 재고 관리의 과제는 운영 비용과 물류의 복잡성을 증가시킵니다. 의료 서비스 제공업체는 호환성 문제를 줄이기 위해 표준화 된 펌프 플랫폼을 선호합니다. 파편화된 디바이스 생태계는 일회용 제품의 소비 확대를 늦추고 있습니다. 복잡한 공급망은 여러 브랜드를 취급하는 병원 및 클리닉에서 전용 일회용 제품을 신속하게 도입하는 것을 제한하고 있습니다.

규제 준수 및 품질 인증 요건: 엄격한 의료기기 규제로 인해 수요 증가세가 둔화되고 있습니다. 제조업체는 멸균 검증, 제품 테스트 및 인증 기준을 충족해야 하기 때문입니다. 규제 준수는 생산 비용을 증가시키고 개발 기간을 연장시킵니다. 소규모 제조업체는 엄격한 규제 요건으로 인해 진입 장벽에 직면하고 있습니다. 인증 요건은 시장 접근에 영향을 미치고 지역별로 경쟁 구도를 형성하고 있습니다. 승인 절차가 길어지면 제품 출시가 늦어지고, 새로운 임상적 요구에 대한 시장의 대응력을 떨어뜨리는 요인으로 작용하고 있습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 전망

제5장 유형별

제6장 용도별

제7장 지역별

제8장 경쟁 구도

제9장 기업 개요

JHS 26.06.11

Global Dedicated Infusion Pump Disposables Market Size And Forecast

Market capitalization in the dedicated infusion pump disposables market reached a significant USD 3.72 Billion in 2025 and is projected to maintain a strong 6.2% CAGR during the forecast period from 2027 to 2033. A company-wide policy adopting digital infusion management systems and medication safety monitoring solutions runs as the main strong factor for strong growth. The market is projected to reach a figure of USD 6.04 Billion by 2033, indicating a significant reassessment of the entire economic landscape.

Global Dedicated Infusion Pump Disposables Market Overview

Dedicated infusion pump disposables refer to consumable components designed specifically for use with infusion pump systems in healthcare settings. These include items such as tubing sets, cartridges, and connectors engineered to ensure accurate medication delivery, patient safety, and compatibility with specific pump models. Procurement is typically driven by hospitals, clinics, and home healthcare providers, with emphasis on reliability, regulatory compliance, and consistent performance. Growing adoption of infusion therapy and patient specific dosing protocols supports steady demand for these specialized consumables.

In market research, dedicated infusion pump disposables is treated as a naming construct that standardizes scope across data collection, comparison, and reporting, ensuring that references to these consumables point to the same underlying category across stakeholders and time.

Demand is shaped by consistent usage in hospital, outpatient, and home care settings where patient safety, dosing accuracy, and regulatory compliance are prioritized over volume growth. Buyers are typically concentrated within healthcare providers and procurement groups, and rather than being driven by rapid expansion, purchasing decisions are influenced by supply reliability, pricing stability, and compliance with medical standards.

With periodic adjustments linked to hospital budgets and clinical procurement cycles rather than spot market fluctuations, pricing tracks input costs and regulatory requirements. Activity in the near future is anticipated to follow healthcare policy developments, infusion therapy adoption rates, and clinical guidelines affecting device and disposable usage.

Global Dedicated Infusion Pump Disposables Market Drivers

The market drivers for the dedicated infusion pump disposables market can be influenced by various factors. These may include:

Growing Demand for Infusion Therapy Across Chronic Disease Treatments: Rising prevalence of chronic conditions such as cancer, diabetes, and cardiovascular diseases is driving higher infusion therapy volumes across healthcare systems. Reliable disposable components are required for each infusion cycle, supporting continuous procurement. Long-term therapies such as chemotherapy, immunotherapy, and antibiotic infusion generate recurring utilization of dedicated infusion pump accessories. Expansion of treatment programs across oncology and critical care units reinforces steady demand patterns. According to recent reports, infusion therapy procedures worldwide exceeded 250 million sessions in 2023, underscoring sustained consumption of disposables.

Expansion of Home Healthcare and Outpatient Treatment Models: Home based and outpatient treatment services are promoting wider adoption of portable infusion pumps. Compatible disposable sets are required for safe operation outside hospital environments. Patients receiving antibiotic therapy, pain management medications, and nutritional infusions rely on home infusion systems. Growth in remote treatment programs encourages greater consumption of disposable infusion accessories. Market analysis indicates home infusion device deployment increased by approximately 12% year over year in North America in 2023, highlighting expanding demand for disposables.

Rising Emphasis on Infection Control and Patient Safety: Strict infection prevention policies are prioritizing the use of single use infusion pump disposables to minimize contamination risks. Sterile tubing, connectors, and syringes are mandated for each infusion procedure under clinical safety protocols. Regulatory authorities reinforce the use of disposable components to maintain safe medication delivery environments. Continuous monitoring of hospital acquired infection rates drives adherence to single use standards. The CDC reported a 7% decline in device associated infections in hospitals enforcing disposable infusion protocols in 2023, demonstrating impact on adoption.

Integration of Smart Infusion Pump Systems: Software driven dose management systems in modern infusion pumps require dedicated administration sets and compatible tubing for accurate operation. Manufacturer approved disposable accessories are procured to maintain system performance and regulatory compliance. Adoption of advanced infusion technologies is increasing demand for specialized disposable products. Digital monitoring features reduce medication errors while relying on consistent disposable component performance. A 2023 survey indicated that approximately 68% of hospitals in Europe and North America were using smart infusion pumps, driving proportional demand for compatible disposables.

Global Dedicated Infusion Pump Disposables Market Restraints

Several factors act as restraints or challenges for the dedicated infusion pump disposables market. These may include:

Rising Cost Pressure Across Healthcare Procurement Budgets: Escalating operational expenditure is restraining adoption, as hospitals and clinics manage growing treatment volumes under constrained budgets. Aggressive pricing negotiations influence procurement strategies, while competition among manufacturers places pressure on profit margins. Cost sensitive purchasing decisions slow expansion of disposable utilization. Budget limitations across smaller healthcare facilities restrict large scale procurement of dedicated infusion pump consumables. Limited financial flexibility further delays the adoption of new disposable technologies across healthcare networks.

Environmental Concerns Related to Medical Waste Generation: Increasing volumes of single use disposables are limiting market expansion, as hospitals generate substantial plastic-based infusion tubing, syringes, and connectors requiring controlled disposal. Sustainability considerations encourage waste reduction evaluation. Regulatory guidelines on medical waste management are restricting operational flexibility. Environmental scrutiny is driving adoption of alternative or reusable solutions at a measured pace. Growing public and institutional focus on eco-friendly healthcare practices amplifies pressure on disposable consumption patterns.

Dependence on Infusion Pump Ecosystem Compatibility: Exclusive compatibility with specific pump models is restraining wider adoption, as facilities operating multiple brands require separate disposable inventories. Inventory management challenges increase operational costs and logistical complexity. Healthcare providers are favoring standardized pump platforms to reduce compatibility issues. Fragmented device ecosystems slow the scaling of disposable consumption. Complex supply chains limit rapid deployment of dedicated disposables in multi brand hospitals and clinics.

Regulatory Compliance and Quality Certification Requirements: Stringent medical device regulations are slowing demand growth, as manufacturers must meet sterilization validation, product testing, and certification standards. Compliance increases production costs and extends development timelines. Smaller manufacturers encounter barriers to entry due to strict regulatory expectations. Certification requirements are influencing market accessibility and shaping competitive dynamics across regions. Extended approval cycles delay product launches, affecting market responsiveness to emerging clinical needs.

Global Dedicated Infusion Pump Disposables Market Segmentation Analysis

The Global Dedicated Infusion Pump Disposables Market is segmented based on Type, Application, and Geography.

Dedicated Infusion Pump Disposables Market, By Type

In dedicated infusion pump disposables market, administration sets dominate adoption as the primary connection between pumps and intravenous access, including drip chambers, flow regulators, and tubing for precise delivery. Syringes occupy a substantial portion, particularly in critical care and neonatal applications, ensuring accurate dosing and sterile transfer. Cartridges are emerging with controlled drug reservoirs in portable and wearable pumps, supporting specialized therapies. Tubing and connectors maintain secure fluid pathways, prevent leaks, and ensure compatibility with intravenous access. The market dynamics for each type are broken down as follows:

Administration Sets: Administration sets dominate the dedicated infusion pump disposables market, as they serve as the primary connection between infusion pumps and intravenous access devices. These sets include drip chambers, flow regulators, and tubing designed for precise medication delivery. Hospitals rely on high quality administration sets for chemotherapy, antibiotics, and continuous infusion therapies. Strong hospital procurement volumes maintain stable demand for this segment.

Syringes: Syringes represent a significant portion of the market, particularly within syringe infusion pump systems used in critical care and neonatal medicine. These disposable syringes ensure accurate drug dosing and sterile medication transfer. Intensive care units and emergency departments frequently utilize syringe pump systems for precise medication control. Growth in intensive care infrastructure strengthens demand for compatible disposable syringes.

Cartridges: Cartridges are witnessing growing adoption in infusion pump systems designed for controlled drug reservoirs. These components store medication before controlled delivery through pump mechanisms. Specialized therapies such as insulin infusion and pain management programs frequently utilize cartridge based systems. Expansion of wearable and portable infusion devices supports the increasing use of disposable cartridges.

Tubing and Connectors: Tubing and connectors maintain fluid transfer pathways within infusion therapy systems. These components ensure leak prevention, secure attachment, and compatibility with intravenous access devices. Hospitals and home healthcare providers rely on high quality tubing materials that resist kinking and maintain consistent fluid flow. Demand remains stable as every infusion cycle requires sterile tubing components.

Dedicated Infusion Pump Disposables Market, By Application

In dedicated infusion pump disposables market, hospitals dominate usage due to large patient volumes requiring continuous infusion across oncology, intensive care, and emergency departments. Ambulatory surgical centers are experiencing rising adoption driven by outpatient procedures and controlled anesthesia delivery. Home healthcare is emerging as the fastest growing application, with portable infusion systems supporting long-term therapy under medical supervision. Specialty clinics focusing on oncology, gastroenterology, and pain management utilize dedicated infusion pumps for safe medication delivery. The market dynamics for each type are broken down as follows:

Hospitals: Hospitals dominate the dedicated infusion pump disposables market, as large patient populations require continuous infusion therapy across departments such as oncology, intensive care, and emergency medicine. High frequency of intravenous drug administration supports strong demand for sterile infusion accessories. Hospitals maintain structured procurement programs with medical device suppliers, ensuring consistent supply of disposable infusion components.

Ambulatory Surgical Centers: Ambulatory surgical centers are witnessing increasing adoption of infusion pump disposables due to rising outpatient surgical procedures. Controlled anesthesia delivery and postoperative pain management frequently rely on infusion pump systems. Disposable infusion accessories support sterile medication administration during surgical recovery periods. Expansion of outpatient surgery infrastructure supports the segment's growth.

Home Healthcare: Home healthcare represents one of the fastest growing application areas in the market. Patients receiving long-term infusion therapies prefer treatment within home environments under medical supervision. Portable infusion pumps require compatible disposable tubing sets, cartridges, and connectors. Growth in home based antibiotic therapy and chronic disease management programs strengthens demand for disposable infusion accessories.

Specialty Clinics: Specialty clinics focusing on oncology, gastroenterology, and pain management regularly utilize infusion therapy systems. These clinics administer chemotherapy drugs, biological therapies, and nutritional infusions through dedicated pump systems. Disposable infusion accessories support safe medication delivery and prevent cross contamination. Rising number of specialty treatment centers supports market expansion.

Dedicated Infusion Pump Disposables Market, By Geography

In dedicated infusion pump disposables market, North America and Europe show steady demand supported by established hospital networks, advanced infusion technologies, and regulatory emphasis on patient safety. Asia Pacific leads in adoption, driven by rapid healthcare infrastructure development across China, India, and Southeast Asia, along with expanding patient populations. Latin America records moderate growth as hospital capacity expansion and government supported procurement reinforce disposable usage. The Middle East and Africa are experiencing gradual uptake, influenced by improving hospital networks, import dependent supply chains, and investments in clinical training and modern infusion therapy systems. The market dynamics for each region are broken down as follows:

North America: North America dominates Dedicated Infusion Pump Disposables due to widespread hospital networks, advanced medical device adoption, and large patient populations requiring infusion therapies. Stringent patient safety regulations support high usage of sterile disposable components. Home healthcare programs and specialized infusion centers reinforce sustained procurement. Hospitals providing oncology and intensive care treatments drive significant demand.

Europe: Europe maintains strong demand for infusion pump disposables supported by established healthcare systems and regulatory focus on infection control. Hospitals providing advanced infusion therapy for oncology and critical care sustain steady procurement. Public healthcare networks continue structured purchasing of disposable components. Specialized care programs reinforce consistent adoption across countries such as Germany, France, and the UK.

Asia Pacific: Asia Pacific is emerging as the fastest growing region due to rising healthcare investments and expanding patient populations requiring infusion therapies. Rapid development of hospital infrastructure across China, India, and Southeast Asia supports growing adoption of infusion pumps. Access to advanced medical treatments drives demand for compatible disposables. Large scale healthcare modernization programs further encourage adoption.

Latin America: Latin America shows steady growth as hospitals expand capacity and infusion therapy programs. Brazil, Mexico, and Argentina invest in medical technology modernization within public and private hospitals. Demand for sterile infusion accessories rises alongside increasing treatment volumes. Government supported procurement programs reinforce adoption of disposable components.

Middle East and Africa: Middle East and Africa are registering gradual growth supported by improving hospital networks and healthcare infrastructure. Adoption of modern infusion therapy systems in urban hospitals drives procurement of compatible disposables. Import dependent medical supply chains influence pricing and availability. Investments in clinical training and hospital development programs further support usage.

Key Players

  • The competitive landscape is increasingly determined by how well players adjust to new consumer values, even though it is still based on brand equity and scale. Even though market consolidation continues to change the strategic map, supply chain ethics, scientific innovation in comfort, and verifiable eco-credentials are now the main areas of strategic differentiation.
  • Key Players Operating in the Global Dedicated Infusion Pump Disposables Market
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • ICU Medical, Inc.
  • Fresenius Kabi AG
  • Terumo Corporation
  • Smiths Medical
  • Moog, Inc.
  • Nipro Corporation
  • Avanos Medical, Inc.
  • Market Outlook and Strategic Implications
  • Growth momentum is remaining stable, while strategic focus is increasingly prioritizing compliance readiness, premiumization, and consumer trust reinforcement. Investment allocation is shifting toward scalable innovation and lifecycle value, as transparency, safety assurance, and access expansion are emerging as long-term competitive differentiators.
  • Key Developments in Dedicated Infusion Pump Disposables Market
  • In 2025, ICU Medical, Inc. introduced its new category of precision IV pumps with FDA clearances for Plum Solo(TM) and updated Plum Duo(TM) devices, expanding its IV Performance Platform that supports compatible disposable infusion sets and components.
  • Recent Milestones

2023: Becton, Dickinson and Company received 510(k) clearance from the U.S. Food and Drug Administration for its updated BD Alaris(TM) Infusion System, enabling full commercial operations and support for modular infusion therapies that use compatible disposable components across acute care settings.

2023: Fresenius Kabi AG was awarded a Breakthrough Technology group purchasing agreement with Premier, Inc. for the Ivenix Infusion System, strengthening access to advanced infusion platforms that interface with dedicated disposables across U.S. health systems.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 MARKET DEFINITION
  • 1.2 MARKET SEGMENTATION
  • 1.3 RESEARCH TIMELINES
  • 1.4 ASSUMPTIONS
  • 1.5 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 DATA MINING
  • 2.2 SECONDARY RESEARCH
  • 2.3 PRIMARY RESEARCH
  • 2.4 SUBJECT MATTER EXPERT ADVICE
  • 2.5 QUALITY CHECK
  • 2.6 FINAL REVIEW
  • 2.7 DATA TRIANGULATION
  • 2.8 BOTTOM-UP APPROACH
  • 2.9 TOP-DOWN APPROACH
  • 2.9 RESEARCH FLOW
  • 2.11 DATA SOURCES

3 EXECUTIVE SUMMARY

  • 3.1 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET OVERVIEW
  • 3.2 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET ESTIMATES AND FORECAST (USD BILLION)
  • 3.3 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET ECOLOGY MAPPING
  • 3.4 COMPETITIVE ANALYSIS: FUNNEL DIAGRAM
  • 3.5 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET ABSOLUTE MARKET OPPORTUNITY
  • 3.6 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET ATTRACTIVENESS ANALYSIS, BY REGION
  • 3.7 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET ATTRACTIVENESS ANALYSIS, BY TYPE
  • 3.8 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET ATTRACTIVENESS ANALYSIS, BY APPLICATION
  • 3.9 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET GEOGRAPHICAL ANALYSIS (CAGR %)
  • 3.9 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET, BY TYPE (USD BILLION)
  • 3.11 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET, BY APPLICATION (USD BILLION)
  • 3.12 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET, BY GEOGRAPHY (USD BILLION)
  • 3.13 FUTURE MARKET OPPORTUNITIES

4 MARKET OUTLOOK

  • 4.1 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET EVOLUTION
  • 4.2 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET OUTLOOK
  • 4.3 MARKET DRIVERS
  • 4.4 MARKET RESTRAINTS
  • 4.5 MARKET TRENDS
  • 4.6 MARKET OPPORTUNITY
  • 4.7 PORTER'S FIVE FORCES ANALYSIS
    • 4.7.1 THREAT OF NEW ENTRANTS
    • 4.7.2 BARGAINING POWER OF SUPPLIERS
    • 4.7.3 BARGAINING POWER OF BUYERS
    • 4.7.4 THREAT OF SUBSTITUTE USER TYPES
    • 4.7.5 COMPETITIVE RIVALRY OF EXISTING COMPETITORS
  • 4.8 VALUE CHAIN ANALYSIS
  • 4.9 PRICING ANALYSIS
  • 4.9 MACROECONOMIC ANALYSIS

5 MARKET, BY TYPE

  • 5.1 OVERVIEW
  • 5.2 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY MATERIAL TYPE
  • 5.3 ADMINISTRATION SETS
  • 5.4 SYRINGES
  • 5.5 CARTRIDGES
  • 5.6 TUBING AND CONNECTORS

6 MARKET, BY APPLICATION

  • 6.1 OVERVIEW
  • 6.2 GLOBAL DEDICATED INFUSION PUMP DISPOSABLES MARKET: BASIS POINT SHARE (BPS) ANALYSIS, BY APPLICATION
  • 6.3 HOSPITALS
  • 6.4 AMBULATORY SURGICAL CENTERS
  • 6.5 HOME HEALTHCARE
  • 6.6 SPECIALTY CLINICS

7 MARKET, BY GEOGRAPHY

  • 7.1 OVERVIEW
  • 7.2 NORTH AMERICA
    • 7.2.1 U.S.
    • 7.2.2 CANADA
    • 7.2.3 MEXICO
  • 7.3 EUROPE
    • 7.3.1 GERMANY
    • 7.3.2 U.K.
    • 7.3.3 FRANCE
    • 7.3.4 ITALY
    • 7.3.5 SPAIN
    • 7.3.6 REST OF EUROPE
  • 7.4 ASIA PACIFIC
    • 7.4.1 CHINA
    • 7.4.2 JAPAN
    • 7.4.3 INDIA
    • 7.4.4 REST OF ASIA PACIFIC
  • 7.5 LATIN AMERICA
    • 7.5.1 BRAZIL
    • 7.5.2 ARGENTINA
    • 7.5.3 REST OF LATIN AMERICA
  • 7.6 MIDDLE EAST AND AFRICA
    • 7.6.1 UAE
    • 7.6.2 SAUDI ARABIA
    • 7.6.3 SOUTH AFRICA
    • 7.6.4 REST OF MIDDLE EAST AND AFRICA

8 COMPETITIVE LANDSCAPE

  • 8.1 OVERVIEW
  • 8.2 KEY DEVELOPMENT STRATEGIES
  • 8.3 COMPANY REGIONAL FOOTPRINT
  • 8.4 ACE MATRIX
    • 8.5.1 ACTIVE
    • 8.5.2 CUTTING EDGE
    • 8.5.3 EMERGING
    • 8.5.4 INNOVATORS

9 COMPANY PROFILES

  • 9.1 OVERVIEW
  • 9.2 BECTON, DICKINSON AND COMPANY
  • 9.3 B. BRAUN MELSUNGEN AG
  • 9.4 ICU MEDICAL, INC.
  • 9.5 FRESENIUS KABI AG
  • 9.6 TERUMO CORPORATION
  • 9.7 SMITHS MEDICAL
  • 9.8 MOOG, INC.
  • 9.9 NIPRO CORPORATION
  • 9.10 AVANOS MEDICAL, INC.
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기